Navigation Links
New grant to study how pediatric brain tumor, ependymoma, develops
Date:6/1/2011

Armed with new grant support, investigators at Nationwide Children's Hospital plan to examine how a common gene of the nervous system leads to the development of a devastating brain tumor, ependymoma. Robert A. Johnson, PhD, principal investigator in the Center for Childhood Cancer at The Research Institute at Nationwide Children's, has received a one-year $75,000 grant from the Matthew Larson Foundation for this research.

Ependymoma, an aggressive tumor that affects the central nervous system, is the first most common brain tumor in children. Ependymoma is chemo-resistant and is incurable in up to 40 percent of cases.

Previously, Dr. Johnson and colleagues at St. Jude Children's Research Hospital discovered that elevated levels of the Ephb2 gene cause embryonic neural stem cells to transform into one of the nine subgroups of ependymoma. The Ephb2 gene normally plays a critical role in cell development throughout the nervous system.

With the Matthew Larson Foundation grant, Dr. Johnson will be able to directly investigate just how the Ephb2 receptor is able to alter normal neural cells and cause ependymoma.

"Many studies have described Ephb2's ability to regulate cellular development in different cell types, but we don't yet know this receptor's role in transforming neural cells," said Dr. Johnson. "It seems that ependymoma develops when Ephb2 inhibits the ability of neural cells to differentiate and complete their cellular development."

During in vitro studies, Dr. Johnson plans to overexpress the Ephb2 receptor in neural stem cells to determine the receptor's role in these cells and to understand whether this overexpression halts cell progression. He also plans to examine the effects different types of mutations in the Ephb2 gene have on neural cell differentiation.

Future studies using a mouse model will help clarify these questions and also help determine if specific Ephb2 mutations can model another one of the nine ependymoma subgroups.

"I expect that our findings will shed light on the biology of these tumors and therefore allow us to develop more effective, targeted therapies," said Dr. Johnson.


'/>"/>

Contact: Erin Pope
Erin.Pope@NationwideChildrens.org
614-355-0495
Nationwide Children's Hospital
Source:Eurekalert

Related medicine news :

1. NIH grant for the move toward clinical trials targeting the lysosomal storage disease MPSIIIB
2. MetLife Foundations grant bolsters media coverage for aging issues
3. UTMB researcher receives $3 million NIH grant to study aging in Mexico
4. NIH awards Salk Institute $5.5 million grant to study Williams syndrome
5. Grant extends funding for the Broads Stanley Center for Psychiatric Research
6. Cedars-Sinais mobile medical clinics receive $500,000 grant from California Community Foundation
7. Immigrants Eat American Junk Food to Fit In: Study
8. Gates Foundation awards Ben-Gurion U. researcher grant for malaria detection using cell phones
9. Grant funds next phase in bringing healthier sorghum closer to underserved communities
10. K-RITH awards grants to foster teamwork among South African TB/HIV scientists
11. $4.5 million grant creates transdisciplinary program to train scholars in child obesity prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... 07, 2016 , ... When it came time to blow out his candles on his 14th ... Pediatric Heart Transplant team at Joe DiMaggio Children’s Hospital surprised his family with ... 30th heart transplant recipient. , “He was playing at home, when we got the ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... and financial consultation services to residents in the Sacramento/Folsom region, is initiating a ... treatment facility. , The Another Choice Another Chance treatment center in Sacramento works ...
(Date:12/7/2016)... ... December 07, 2016 , ... AlignLife clinics nationwide are giving back to ... fortunate enough to receive bountiful gifts wrapped tightly under a Christmas Tree. AlignLife ... children of the world. , In exchange for generous donations, customers will receive a ...
(Date:12/7/2016)... ... 2016 , ... Sharon Kleyne, host of the nationally syndicated radio program, The ... of America, declared on her radio program in November 2016 the need to educate ... bullies attack leaders in corporate America, they are trying to take advantage of successful ...
(Date:12/7/2016)... Phoenix, Arizona (PRWEB) , ... December 07, 2016 , ... ... Juvederm®, Just in Time For The Holiday Party Season. Save Up To 33% Off ... and Laser Salon is providing the Phoenix Valley with Delightful Deals on ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... , Dec. 6, 2016  "Blood Tests ... cancers announced ....." The Diagnostic, Monitoring and ... in cancer diagnostics is occurring using in vitro ... new company with impressive backing, has announced a ... technology is moving faster than the market. New ...
(Date:12/6/2016)... 6, 2016 The pen needles market is ... USD 1.65 billion in 2016, growing at a CAGR ... 2021. Over the years, the pen needles market ... to the growing demand for safety injections in the ... of safety pen needles with an aim to reduce ...
(Date:12/6/2016)... Dec. 6, 2016  BTL Aesthetics today announced ... its BTL Vanquish ME device was effectively redesigned ... to the targeted tissue. The result: Significantly better ... with BTL Vanquish ME versus BTL Vanquish. ... network and their patients with the most highly-advanced ...
Breaking Medicine Technology: